MICHELI, VALERIA
 Distribuzione geografica
Continente #
EU - Europa 1.314
NA - Nord America 959
AS - Asia 571
SA - Sud America 18
AF - Africa 16
OC - Oceania 9
Totale 2.887
Nazione #
US - Stati Uniti d'America 927
DE - Germania 388
IT - Italia 314
GB - Regno Unito 289
CN - Cina 243
SG - Singapore 111
SE - Svezia 90
IN - India 57
RU - Federazione Russa 52
HK - Hong Kong 48
ID - Indonesia 46
IE - Irlanda 45
FR - Francia 38
CA - Canada 31
DK - Danimarca 21
KR - Corea 17
FI - Finlandia 15
CH - Svizzera 14
UA - Ucraina 12
VN - Vietnam 12
AU - Australia 9
BE - Belgio 9
TR - Turchia 9
BR - Brasile 8
NL - Olanda 8
CO - Colombia 7
JP - Giappone 6
IR - Iran 5
RO - Romania 5
UG - Uganda 5
ET - Etiopia 4
SA - Arabia Saudita 4
TW - Taiwan 4
NO - Norvegia 3
SC - Seychelles 3
ZA - Sudafrica 3
AM - Armenia 2
ES - Italia 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 2.888
Città #
Frankfurt am Main 345
Southend 263
Chandler 148
Milan 137
Fairfield 105
Seattle 67
Singapore 67
Wilmington 56
Ashburn 47
Dublin 45
Princeton 42
Hong Kong 41
Woodbridge 39
Cambridge 37
Ann Arbor 36
Beijing 32
Houston 29
Boardman 25
Jakarta 23
Redwood City 21
Rome 20
Toronto 20
Bengaluru 18
Dearborn 17
Phoenix 17
Guangzhou 16
Nanjing 16
Margão 13
New York 13
Shanghai 12
Des Moines 11
Segrate 11
Turin 11
Dong Ket 10
San Valentino Torio 10
San Diego 9
Helsinki 8
London 8
Nanchang 8
Jinan 7
Kent 7
Brussels 6
Istanbul 6
Mumbai 6
Santa Clara 6
Shenyang 6
Zurich 6
Cassano Magnago 5
Central District 5
Changsha 5
Falls Church 5
Fremont 5
Jacksonville 5
Kampala 5
Los Angeles 5
Medellín 5
Paris 5
Seoul 5
Yongin-si 5
Berlin 4
Colorado Springs 4
Melbourne 4
Ottawa 4
Riyadh 4
Taipei 4
Tokyo 4
Varedo 4
Wuhan 4
Addis Ababa 3
Bandung 3
Bollate 3
Buffalo 3
Fars 3
Hangzhou 3
Hebei 3
Hefei 3
Hyderabad 3
Jiaxing 3
Montreal 3
Monza 3
Naples 3
Nova Milanese 3
Ostermundigen 3
Pontianak 3
Redmond 3
San Bruno 3
St Petersburg 3
São Paulo 3
Tianjin 3
Washington 3
Andover 2
Baltimore 2
Bandar Lampung 2
Belo Horizonte 2
Boston 2
Bovisio-Masciago 2
Bühl 2
Chicago 2
Coimbatore 2
Duncan 2
Totale 2.085
Nome #
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 317
Improvement of ALT decay kinetics by all-oral HCV treatment : role of NS5A inhibitors and differences with IFN-based regimens 223
Favorable therapeutic response with an antiretroviral salvage regimen in an HIV-1-positive subject infected with a CRF11-cpx virus 172
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy : 48-Week results of a randomized trial 172
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 152
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 142
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 139
Time and mode of epidemic hcv-2 subtypes spreading in Europe: Phylodynamics in Italy and Albania 133
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response 132
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 123
A perspective Italian study on HIV-1 resistance in naive patients for antiretroviral therapy 109
Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy 104
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 101
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI 99
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 97
Geographical reconstruction of the SARS‐CoV‐2 outbreak in Lombardy (Italy) during the early phase 90
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 77
Viral bloodstream detection in mpox patients: An observational multicentric study 72
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 68
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 65
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation 62
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 61
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 61
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 50
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 43
Immunological failure in an HIV élite controller: Possible role of indirect markers of inflammation and benefit of antiretroviral therapy 38
Two individuals with potential monkeypox virus reinfection 31
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 29
Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient 28
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies 25
A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge? 24
null 3
Totale 3.042
Categoria #
all - tutte 11.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020294 0 0 0 41 17 29 46 22 57 38 18 26
2020/2021310 15 19 25 16 40 34 20 47 31 21 23 19
2021/2022439 29 24 35 10 43 25 34 21 52 58 14 94
2022/2023532 62 63 46 46 32 82 11 37 63 16 45 29
2023/2024716 23 41 34 40 150 54 70 65 28 48 76 87
2024/2025291 77 115 54 45 0 0 0 0 0 0 0 0
Totale 3.042